Independent educational platform dedicated to medication access research, pharmaceutical policy awareness, and public health education.
Understand what your medication really costs
and how to pay less
For HIV, hepatitis C, weight-management, and blood-thinner prescriptions, the price you are quoted is rarely the price you have to pay. We explain what these medications actually cost and walk you through the assistance programs, copay cards, and public programs that can lower it — in plain language.
“When a prescription costs more than a paycheck, the problem is rarely a lack of options — it is that the options are buried, confusing, or never explained. We exist to surface them.”
We route patients to every free and low-cost pathway first, in plain language anyone can act on.
Four areas where cost gets in the way of care
We stay narrow on purpose. In each of these areas, treatment works — but the price keeps people from starting or staying on it. We cover what each medication costs and every way to pay less.
Modern antiretroviral therapy can suppress HIV to undetectable levels within weeks — making transmission effectively impossible and life expectancy equivalent to the general population. But choosing the right regimen, understanding costs, and accessing assistance programs requires detailed, up-to-date information.
Hepatitis C is now curable in 95%+ of patients with 8–12 weeks of direct-acting antivirals — yet millions remain undiagnosed or untreated due to cost barriers and lack of awareness. We cover genotype-specific treatment regimens, cure rates, insurance coverage, and how to access patient assistance programs.
Blood thinners like Eliquis and Xarelto prevent strokes and dangerous clots, but the manufacturer list price runs roughly $600 a month. Most patients never need to pay that: copay cards can bring the cost to as little as $10 a month for eligible insured patients, and assistance programs help those who are uninsured. We map every route.
GLP-1 receptor agonists have redefined what is medically achievable in obesity treatment. With 15–22% body weight reductions now possible and strong cardiovascular benefit data, the conversation has shifted from willpower to biology. We cover the clinical evidence, candidacy criteria, and how to discuss options with a physician.
The need is not abstract
These conditions affect tens of millions of people in the United States. For many of them, the deciding factor in whether they get treated is not the medicine — it is whether they can afford it.
Cost should not decide treatment. Choosing an HIV regimen, starting hepatitis C treatment, or staying on a prescribed blood thinner are decisions that work best when cost is not the deciding factor. Accurate, physician-reviewed information — including the assistance programs that lower what patients pay — supports better choices at the point of decision.
How every page is produced
Cost guidance is only useful if it is accurate. Here is what stands behind every page.
-
1Written by qualified health communicators
Every article is written by a medical writer with clinical background or advanced training in the relevant therapeutic area — not by generalists or content mills. Authors hold credentials including CMPP certification, PhDs in life sciences, and backgrounds in clinical research or pharmacy.
-
2Reviewed by a licensed physician specialist
Each article is reviewed for clinical accuracy by a physician with specialty training in the relevant area — including board-certified infectious disease specialists, hepatologists, and cardiology and hematology specialists. Reviewer credentials, affiliation, and LinkedIn profile are published transparently on every page.
-
3Referenced against primary clinical evidence
Every clinical claim is referenced to its source: FDA prescribing information, published clinical trial results, DHHS treatment guidelines, AASLD guidelines, or equivalent authoritative sources. References are cited inline and listed at the end of each article.
-
4Updated to reflect current guidelines
Prices, assistance programs, and treatment guidelines change often. We review and update pages when they do, and each page shows a visible last-reviewed date.
-
5Editorially independent — no commercial influence
SunnyPharma does not accept sponsored content, affiliate placements, or advertising from pharmaceutical manufacturers. Our editorial decisions are made solely on the basis of clinical relevance and patient need. We do not sell medication.
The same standard on every page
A few things hold true across everything we publish.
All dosing, efficacy figures, and safety information are verified against current FDA prescribing information and published clinical trial data.
Every article carries a named, credentialed medical reviewer whose specialization is relevant to the topic. No anonymous review.
Clinical claims link to primary sources — trial publications, FDA labels, DHHS and AASLD guidelines — not secondary media reports.
No pharmaceutical advertising, no sponsored content, no affiliate commissions on medication purchases. Commercial separation is absolute.
Every page shows a visible publication date and last-reviewed date, matched to the schema markup for accurate Google indexing.
Clinical precision is non-negotiable — but so is clarity. Content is written to be understood by an informed adult without a medical degree.
Who stands behind this content
SunnyPharma is produced by an independent editorial team and reviewed by licensed physicians. Each article names the writer and the physician who reviewed it.
Provides editorial oversight of medical content across SunnyPharma, working with our reviewers to keep each page accurate and current.
Read editorial standards →Our content does not constitute medical advice. SunnyPharma articles are designed to support informed conversations with your healthcare provider — not to replace them. Always consult a licensed clinician before making changes to your treatment.